The Efficacy and Safety of CKD516 Combined With Durvalumab in Patient Refractory Solid Tumors
Clinical trial NCT04696848 · TERMINATED
Trial details
- NCT number
- NCT04696848
- Sponsor
- Tae Won Kim
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-24
- Primary completion
- 2023-03-09
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.